{"schema_version":"1","generated_at":"2026-10-28T01:14:50.058Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-steffin","json_url":"https://www.findmykol.com/kol/david-steffin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-steffin","name":"David Steffin","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Baylor College of Medicine","institution_url":"https://www.findmykol.com/institution/baylor-college-of-medicine","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1063779106","orcid":"0000-0002-0881-3167","openalex":"A5060697976"},"summary":"David Steffin is an Oncology physician affiliated with Baylor College of Medicine. OpenAlex indexes 49 publications with 514 citations (h-index 8); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":49,"cited_by_count":514,"h_index":8,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07513194","title":"GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)","phase":"PHASE1","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Baylor College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT07513194","trial_url":"https://www.findmykol.com/trial/NCT07513194"},{"nct":"NCT06198296","title":"Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Baylor College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT06198296","trial_url":"https://www.findmykol.com/trial/NCT06198296"},{"nct":"NCT04715191","title":"Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Baylor College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT04715191","trial_url":"https://www.findmykol.com/trial/NCT04715191"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"National Marrow Donor Program","program_year":2024,"amount_usd":214.51,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063779106"},{"payer":"SOBI, INC","program_year":2024,"amount_usd":39.04,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063779106"},{"payer":"National Marrow Donor Program","program_year":2023,"amount_usd":1117.83,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063779106"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1063779106","source":"payments"},"publications":{"total":42,"shown":5,"withheld":37,"matched_by":"OpenAlex author record","recent":[{"title":"Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma","year":2025,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-025-03513-0","status":"verified"},{"title":"Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors","year":2025,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.31557","status":"verified"},{"title":"553 A phase I clinical trial of allogeneic NKT cells expressing a CD19-specific CAR in patients with relapsed or refractory B cell malignancies: an interim analysis","year":2025,"journal":"Regular and Young Investigator Award Abstracts","source_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0553","status":"verified"},{"title":"EXTH-46. IL-15 armored glypican-3 chimeric antigen receptor T cells exhibit antitumor in vitro and in murine models of glioblastoma","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf201.1380","status":"verified"},{"title":"Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among at‐Risk Childhood Cancer Survivors in the US","year":2025,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.32124","status":"verified"}],"source":"works"},"contact":{"address_1":"6701 FANNIN ST STE 1510","address_2":"CLINICAL CARE CENTER, TEXAS CHILDREN'S HOSPITAL","city":"Houston","state":"TX","zip":"77030","phone":"832-822-4242","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1063779106","source":"identity"},"similar":[{"name":"Christie Ballantyne","slug":"christie-ballantyne","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/christie-ballantyne","json_url":"https://www.findmykol.com/kol/christie-ballantyne/profile.json"},{"name":"Biykem Bozkurt","slug":"biykem-bozkurt","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/biykem-bozkurt","json_url":"https://www.findmykol.com/kol/biykem-bozkurt/profile.json"},{"name":"Malcolm Brenner","slug":"malcolm-brenner","institution":"Baylor College of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/malcolm-brenner","json_url":"https://www.findmykol.com/kol/malcolm-brenner/profile.json"},{"name":"Garabed Eknoyan","slug":"garabed-eknoyan","institution":"Baylor College of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/garabed-eknoyan","json_url":"https://www.findmykol.com/kol/garabed-eknoyan/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":1,"publications":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-03-29","provider_certified":"2023-03-29","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}